| (210) | Number of the EPO application | 17731785 |
| (220) | Filing date of the EPO application | 2017.06.13 |
| (80) | EPO patent specification publication (B) | EPB nr. 13/2024, 2024.03.27 |
| (110) | EPO patent number | 3468990 |
| (11) | Number of the document | MD 3468990 T2 |
| (21) | Number of the application | e 2019 0468 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | HU Ying, US;
LATUSZEK Adrianna, US;
ROMANO Carmelo, US;
OLSON William, US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (54) | Title of the invention | Anti-c5 antibodies and uses thereof |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/18 (2006.01.01); A61K 39/00 (2006.01.01); A61P 1/04 (2006.01.01); A61P 3/10 (2006.01.01); A61P 9/00 (2006.01.01); A61P 9/10 (2006.01.01); A61P 11/00 (2006.01.01); A61P 11/06 (2006.01.01); A61P 13/00 (2006.01.01); A61P 13/10 (2006.01.01); A61P 13/12 (2006.01.01); A61P 17/02 (2006.01.01); A61P 19/02 (2006.01.01); A61P 21/04 (2006.01.01); A61P 25/00 (2006.01.01); A61P 25/08 (2006.01.01); A61P 25/16 (2006.01.01); A61P 25/28 (2006.01.01); A61P 27/02 (2006.01.01); A61P 29/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.11.30 |
| (30) | Priority | 201662349705 P, 2016.06.14, US; 201662405561 P, 2016.10.07, US; 201662422107 P, 2016.11.15, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/US2017/037226, 2017.06.13 |
| (87) | International publication | WO 2017/218515, 2017.12.21 |